|
Market Closed -
London S.E.
11:35:03 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 38.60 GBX | -1.03% |
|
-12.27% | +8.89% |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| 09-08 | Novacyt S.A. Launches IVDR-Certified Yourgene Insight DPYD Assay | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Medical Devices
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 70.44B | |||||
| 50.31B | |||||
| 47.51B | |||||
| 42.91B | |||||
| 40.39B | - | - | - | - | - |
- Stock Market
- Stocks
- ALNOV Stock
- NCYT Stock
- Charts Novacyt
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
